{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:06:28Z","timestamp":1762113988634,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"19-20","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A070001"],"award-info":[{"award-number":["A070001"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["FPR08A2-130"],"award-info":[{"award-number":["FPR08A2-130"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.cca.2011.06.014","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T21:14:24Z","timestamp":1309036464000},"page":"1831-1834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effect of genetic polymorphisms on the pharmacokinetics and efficacy of glimepiride in a Korean population"],"prefix":"10.1016","volume":"412","author":[{"given":"Hyun-Jung","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Youn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youn-Gyoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Yeon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Seong","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Wook","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-Gun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.06.014_bb0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"year":"2004","series-title":"Diabetes and obesity: urgent action needed","author":"IDF","key":"10.1016\/j.cca.2011.06.014_bb0010"},{"key":"10.1016\/j.cca.2011.06.014_bb0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2165\/00003495-199855040-00007","article-title":"Glimepiride. A review of its use in the management of type 2 diabetes mellitus","volume":"55","author":"Langtry","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.cca.2011.06.014_bb0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-2007-979838","article-title":"Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells","volume":"28","author":"Kramer","year":"1996","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cca.2011.06.014_bb0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-979829","article-title":"An overview of the safety and tolerance of glimepiride","volume":"28","author":"Schneider","year":"1996","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cca.2011.06.014_bb0030","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0149-2918(03)80109-1","article-title":"Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience","volume":"25","author":"Massi-Benedetti","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.cca.2011.06.014_bb0035","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/diacare.19.11.1194","article-title":"Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group","volume":"19","author":"Rosenstock","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2011.06.014_bb0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0005-2736(94)90177-5","article-title":"Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics","volume":"1191","author":"Muller","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2011.06.014_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0149-2918(04)90006-9","article-title":"Effects of glimepiride on insulin secretion and sensitivity in patients with recently diagnosed type 2 diabetes mellitus","volume":"26","author":"Kabadi","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.cca.2011.06.014_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diacare.20.1.7","article-title":"Characteristics related to poor glycemic control in NIDDM patients in community practice","volume":"20","author":"Blaum","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2011.06.014_bb0055","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/diacare.17.10.1100","article-title":"Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study","volume":"17","author":"Hermann","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2011.06.014_bb0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1464-5491.2001.00449.x","article-title":"Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53)","volume":"18","author":"Gloyn","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.cca.2011.06.014_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2337\/diabetes.47.4.598","article-title":"Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene","volume":"47","author":"Hansen","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0070","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2337\/db07-0440","article-title":"Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study","volume":"56","author":"Pearson","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/FPC.0b013e328300e8c5","article-title":"Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea","volume":"18","author":"Pearson","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.cca.2011.06.014_bb0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/db06-0461","article-title":"Screening of 134 single nucleotide polymorphisms (SNPs) previously associated with type 2 diabetes replicates association with 12 SNPs in nine genes","volume":"56","author":"Willer","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0085","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s00125-008-1039-3","article-title":"Exon sequencing and association analysis of polymorphisms in TCF7L2 with type 2 diabetes in a Chinese population","volume":"51","author":"Ren","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2011.06.014_bb0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.cca.2011.06.014_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.diabres.2009.04.024","article-title":"Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population","volume":"85","author":"Luo","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cca.2011.06.014_bb0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10038-007-0231-5","article-title":"Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects","volume":"53","author":"Miyake","year":"2008","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cca.2011.06.014_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/DMDI.1996.13.1.69","article-title":"Pharmacokinetics and pharmacodynamics of the hydroxymetabolite of glimepiride (Amaryl) after intravenous administration","volume":"13","author":"Badian","year":"1996","journal-title":"Drug Metabol Drug Interact"},{"key":"10.1016\/j.cca.2011.06.014_bb0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2710.2006.00766.x","article-title":"Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans","volume":"31","author":"Yun","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.cca.2011.06.014_bb0115","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.2337\/db06-0474","article-title":"Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes","volume":"55","author":"Cauchi","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa062418","article-title":"TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program","volume":"355","author":"Florez","year":"2006","journal-title":"NEJM"},{"key":"10.1016\/j.cca.2011.06.014_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1741-7015-4-34","article-title":"Effects of the diabetes linked TCF7L2 polymorphism in a representative older population","volume":"4","author":"Melzer","year":"2006","journal-title":"BMC Med"},{"key":"10.1016\/j.cca.2011.06.014_bb0130","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.2337\/db06-0381","article-title":"Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals","volume":"55","author":"Saxena","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0135","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00125-008-0926-y","article-title":"Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion","volume":"51","author":"Kirchhoff","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2011.06.014_bb0140","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00125-008-1129-2","article-title":"Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population","volume":"51","author":"Gonzalez-Sanchez","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2011.06.014_bb0145","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1007\/s00125-007-0746-5","article-title":"Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men","volume":"50","author":"Dahlgren","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2011.06.014_bb0150","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.2337\/db07-0055","article-title":"TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population","volume":"56","author":"Loos","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0155","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00125-009-1266-2","article-title":"TCF7L2 variants are associated with increased proinsulin\/insulin ratios but not obesity traits in the Framingham Heart Study","volume":"52","author":"Stolerman","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2011.06.014_bb0160","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1074\/jbc.M411487200","article-title":"TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta","volume":"280","author":"Yi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2011.06.014_bb0165","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/diabetes.53.9.2181","article-title":"Therapeutic strategies based on glucagon-like peptide 1","volume":"53","author":"Deacon","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0170","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.2337\/db06-0338","article-title":"Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance","volume":"55","author":"Damcott","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/db06-0860","article-title":"Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans","volume":"56","author":"Lehman","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00125-006-0502-2","article-title":"Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population","volume":"50","author":"Chandak","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2011.06.014_bb0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00125-006-0588-6","article-title":"A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population","volume":"50","author":"Horikoshi","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2011.06.014_bb0190","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-007-0618-z","article-title":"Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population","volume":"50","author":"Hayashi","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2011.06.014_bb0195","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00109-006-0108-7","article-title":"Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women","volume":"84","author":"Humphries","year":"2006","journal-title":"J Mol Med"},{"key":"10.1016\/j.cca.2011.06.014_bb0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00125-006-0477-z","article-title":"Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort","volume":"50","author":"van Vliet-Ostaptchouk","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2011.06.014_bb0205","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.2337\/db06-0341","article-title":"Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample","volume":"55","author":"Scott","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0210","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05616","article-title":"A genome-wide association study identifies novel risk loci for type 2 diabetes","volume":"445","author":"Sladek","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cca.2011.06.014_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2005.04.005","article-title":"Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis","volume":"108","author":"Schulz","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cca.2011.06.014_bb0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cbpb.2005.05.048","article-title":"Regulation of the mammalian heart function by nitric oxide","volume":"142","author":"Massion","year":"2005","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"10.1016\/j.cca.2011.06.014_bb0225","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2337\/diabetes.50.6.1311","article-title":"A neuronal isoform of nitric oxide synthase expressed in pancreatic beta-cells controls insulin secretion","volume":"50","author":"Lajoix","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0230","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/diabetes.55.04.06.db05-1532","article-title":"Mechanisms of time-dependent potentiation of insulin release: involvement of nitric oxide synthase","volume":"55","author":"Gunawardana","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0235","first-page":"101","article-title":"Molecular biology of adenosine triphosphate-sensitive potassium channels","volume":"20","author":"Aguilar-Bryan","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cca.2011.06.014_bb0240","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2337\/diabetes.53.5.1360","article-title":"Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region","volume":"53","author":"Florez","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0245","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.2337\/db09-0143","article-title":"Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel","volume":"58","author":"Hamming","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.06.014_bb0250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10038-006-0087-0","article-title":"Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin","volume":"52","author":"Shikata","year":"2007","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cca.2011.06.014_bb0255","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","article-title":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action","volume":"117","author":"Shu","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2011.06.014_bb0260","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1464-5491.2000.00305.x","article-title":"Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes","volume":"17","author":"Pearson","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.cca.2011.06.014_bb0265","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1210\/jc.2005-2323","article-title":"The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes","volume":"91","author":"Sesti","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2011.06.014_bb0270","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/dc07-2248","article-title":"Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients","volume":"31","author":"Feng","year":"2008","journal-title":"Diabetes Care"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111003470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111003470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:00:53Z","timestamp":1762113653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111003470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":54,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0009898111003470"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.06.014","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of genetic polymorphisms on the pharmacokinetics and efficacy of glimepiride in a Korean population","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2011.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}